Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yodit Seifu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Academic Radiology|May 1, 2013
Nonparametric multivariate inference on shift parametersJohn E Kolassa, Yodit Seifu
International Urogynecology Journal|October 19, 2011
Time-to-effect with darifenacin in overactive bladder: a pooled analysisVik Khullar, Jenelle Foote, Yodit Seifu, et al.
Journal of Biopharmaceutical Statistics|February 9, 2023
Estimand in benefit-risk assessmentXinru Ren, X Gregory Chen, William Wang, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trialLawrence Hookey, Gerald Bertiger, Kenneth Lee Johnson, et al.
Pharmaceutical Statistics|November 1, 2019
The win ratio: Impact of censoring and follow-up time and use with nonproportional hazardsGaohong Dong, Bo Huang, Yu-Wei Chang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2008
Initial combination therapy compared with monotherapy in diabetic hypertensive patientsJames R Sowers, Guido Lastra, Ricardo Rocha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year studyKlemens Budde, John Curtis, Gregory Knoll, et al.
Journal of Biopharmaceutical Statistics|December 22, 2022
Design of paediatric trials with benefit-risk endpoints using a composite score of adverse events of interest (AEI) and win-statisticsYodit Seifu, Shahrul Mt-Isa, Kyle Duke, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or MisconductDavid Knepper, Anne S Lindblad, Gaurav Sharma, et al.
Journal of Hypertension|November 4, 2010
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapySuzanne Oparil, Thomas Giles, Elizabeth O Ofili, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Academic Radiology|May 1, 2013
Nonparametric multivariate inference on shift parametersJohn E Kolassa, Yodit Seifu
International Urogynecology Journal|October 19, 2011
Time-to-effect with darifenacin in overactive bladder: a pooled analysisVik Khullar, Jenelle Foote, Yodit Seifu, et al.
Journal of Biopharmaceutical Statistics|February 9, 2023
Estimand in benefit-risk assessmentXinru Ren, X Gregory Chen, William Wang, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trialLawrence Hookey, Gerald Bertiger, Kenneth Lee Johnson, et al.
Pharmaceutical Statistics|November 1, 2019
The win ratio: Impact of censoring and follow-up time and use with nonproportional hazardsGaohong Dong, Bo Huang, Yu-Wei Chang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2008
Initial combination therapy compared with monotherapy in diabetic hypertensive patientsJames R Sowers, Guido Lastra, Ricardo Rocha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year studyKlemens Budde, John Curtis, Gregory Knoll, et al.
Journal of Biopharmaceutical Statistics|December 22, 2022
Design of paediatric trials with benefit-risk endpoints using a composite score of adverse events of interest (AEI) and win-statisticsYodit Seifu, Shahrul Mt-Isa, Kyle Duke, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or MisconductDavid Knepper, Anne S Lindblad, Gaurav Sharma, et al.
Journal of Hypertension|November 4, 2010
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapySuzanne Oparil, Thomas Giles, Elizabeth O Ofili, et al.
Pageof 2